In a new letter, researchers from Wuhan Children’s Hospital in Wuhan, China, have provided insights on early-onset SARS-CoV-2 infection in neonates
In their hospital, the authors treated 33 neonates born to mothers with COVID-19. Their account describes outcomes in three of the neonates who also were diagnosed with the virus. Data included were collected from January 2020 to February 2020.
Born at 40 weeks’ gestation to a mother with COVID-19 pneumonia, the infant in Case 1 was lethargic and had a fever on Day 2 of life. Chest x-ray showed pneumonia but all lab tests other than for procalcitonin were normal. Nasopharyngeal and anal swabs were positive for SARS-CoV-2 on Days 2 and 4 but negative on Day 6.
Also born to a mother with confirmed COVID-19 pneumonia, the infant in Case 2 had lethargy, vomiting and fever. Chest x-ray showed pneumonia and lab tests showed leukocytosis, lymphocytopenia, and an elevated creatine kinase-MB fraction. As with the infant in Case 1, nasopharyngeal and anal swabs were positive for SARS-CoV-2 on Days 2 and 4 but negative on Day 6.
The infant in Case 3 required resuscitation after cesarean at 31 weeks, 2 days for fetal distress and maternal COVID-19 pneumonia. He was treated with noninvasive ventilation, caffeine, and antibiotics for neonatal respiratory distress syndrome and pneumonia, which resolved on Day 14 of life. Antibiotics also were administered for suspected sepsis. On Days 2 and 4, nasopharyngeal and anal swabs were positive for SARS-CoVo-2 and negative on Day 7.
The authors described symptoms in all 33 infants-including the three infected neonates-as “mild” and their outcomes as “favorable.” They speculated of the most seriously ill neonate that he “may have been symptomatic from prematurity, asphyxia, and sepsis, rather than SARS-CoV-2 infection.”
The researchers concluded that “it is crucial to screen pregnant women and implement strict infection control measures, quarantine of infected mothers, and close monitoring of neonates at risk of COVID-19.”